Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23444220 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy
Condition: Breast Cancer
Interventions: Drug: Gemcitabine;   Drug: Sorafenib;   Drug: Placebo;   Drug: Capecitabine

Indicates status has not been verified in more than two years